Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis,...
Read more
Vesselon (www.vesselon.com) an oncology therapeutics company, announced the acquisition of an FDA-approved drug Imagent. Vesselon will use Imagent to create...
Read more
ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), and...
Read more
GlaxoSmithKline announced that the European Commission has granted marketing authorisation for two new methods of administering Nucala (mepolizumab): a pre-filled...
Read more
Neuropore Therapies, Inc. announce that it entered into a collaboration with BenevolentAI to evaluate molecular targets implicated in progressive degenerative...
Read more
Dr. Reddy’s Laboratories Ltd, along with its subsidiaries together referred to as “Dr. Reddy’s” announced the launch of Pregabalin Capsulesa...
Read more
Amicus Therapeutics announced positive interim results from its CLN6 Batten disease gene therapy program licensed from the Abigail Wexner Research...
Read more
Amicus Therapeutics announced that the Agency of Medicines, Food and Medical Devices (ANMAT) in Argentina has granted approval for the...
Read more
Daiichi Sankyo Company, Limited announced that the U.S. FDA approved TURALIO as the first and only treatment for adult patients...
Read more
GlycoMimetics, Inc. reported that Pfizer Inc. announced that the Phase 3 Rivipansel (GMI-1070): Evaluating Safety, Efficacy and Time to Discharge...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
